SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-21-001784
Filing Date
2021-08-04
Accepted
2021-08-03 18:02:08
Documents
15
Period of Report
2021-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20210802.htm   iXBRL 8-K 16181
2 PRESS RELEASE axim_ex99z1.htm EX-99.1 14176
7 IMAGE axim8k_1.jpg GRAPHIC 38710
  Complete submission text file 0001096906-21-001784.txt   285153

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20210802_def.xml EX-101.DEF 1842
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20210802_lab.xml EX-101.LAB 20951
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20210802_pre.xml EX-101.PRE 13981
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20210802.xsd EX-101.SCH 33533
8 EXTRACTED XBRL INSTANCE DOCUMENT axim-20210802_htm.xml XML 2450
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 211141410
SIC: 2834 Pharmaceutical Preparations